Skip to main content

No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women

Osteoporosis International volume 17, pages 1122–1132 (2006)Cite this article

Abstract

Introduction

Vitamin K functions as a co-factor in the post-translational carboxylation of several bone proteins, including osteocalcin.

Aim

The aim of this study was to investigate the relationship between vitamin K1 intake and bone mineral density (BMD) and fracture risk in a perimenopausal Danish population.

Design

The study was performed within the Danish Osteoporosis Prevention Study (DOPS), including a population-based cohort of 2,016 perimenopausal women. During the study approximately 50% of the women received hormone replacement therapy (HRT). Associations between vitamin K1 intake and BMD were assessed at baseline and after 5-years of follow-up (cross-sectional design). Moreover, associations between vitamin K1 intake and 5-year and 10-year changes in BMD were studied (follow-up design). Finally, fracture risk was assessed in relation to vitamin K1 intake (nested case–control design).

Results

In our cohort, dietary vitamin K1 intake (60 μg/day) was close to the daily intake recommended by the Food and Agriculture Organization (FAO). Cross-sectional and longitudinal analyses showed no associations between intake of vitamin K1 and BMD of the femoral neck or lumbar spine. Neither did BMD differ between those 5% that had the highest vitamin K1 intake and those 5% that had the lowest. During the 10-years of follow-up, 360 subjects sustained a fracture (cases). In a comparison between the cases and 1,440 controls, logistic regression analyses revealed no difference in vitamin K1 intake between cases and controls.

Conclusion

In a group of perimenopausal and early postmenopausal women, vitamin K1 intake was not associated with effects on BMD or fracture risk.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Booth SL, Suttie J (1998) Dietary intake and adequacy of vitamin K1. J Nutr 128:785–788

    PubMed  CAS  Google Scholar 

  2. Hara K, Akiyama Y, Tajima T, Shiraki M (1993) Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro. J Bone Miner Res 8:535–542

    PubMed  CAS  Google Scholar 

  3. Takeuchi Y, Suzawa M, Fukumoto S, Fujita T (2000) Vitamin K(2) inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. Bone 27:769–776

    Article  PubMed  CAS  Google Scholar 

  4. Berkner KL (2000) The vitamin K-dependent carboxylase. J Nutr 130:1877–1880

    PubMed  CAS  Google Scholar 

  5. Kalkwarf HJ, Khoury JC, Bean J, Elliot JG (2004) Vitamin K, bone turnover, and bone mass in girls. Am J Clin Nutr 80:1075–1080

    PubMed  CAS  Google Scholar 

  6. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD (1994) Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9:1591–1595

    PubMed  CAS  Google Scholar 

  7. Booth SL, Broe KE, Peterson JW, Cheng DM, Dawson-Hughes B, Gundberg CM, Cupples LA, Wilson PWF, Kiel DP (2004) Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab 89:4904–4909

    Article  PubMed  CAS  Google Scholar 

  8. Szulc P, Chapuy MC, Meunier PJ, Delmas PD (1996) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 18:487–488

    Article  PubMed  CAS  Google Scholar 

  9. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD (1997) Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS study. J Clin Endocrinol Metab 82:719–724

    Article  PubMed  CAS  Google Scholar 

  10. Szulc P, Chapuy MC, Meunier PJ, Delmas PD (1993) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91:1769–1774

    Article  PubMed  CAS  Google Scholar 

  11. Hodges SJ, Akesson K, Vergnaud P, Obrant K, Delmas PD (1993) Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res 8:1241–1245

    Article  PubMed  CAS  Google Scholar 

  12. Hart JP, Shearer MJ, Klenerman L, Catterall A, Reeve J, Sambrook PN, Dodds RA, Bitensky L, Chayen J (1985) Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J Clin Endocrinol Metab 60:1268–1269

    Article  PubMed  CAS  Google Scholar 

  13. Luukinen H, Kakonen SM, Pettersson K, Koski K, Laippala P, Lovgren T, Kivela SL, Vaananen HK (2000) Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15:2473–2478

    Article  PubMed  CAS  Google Scholar 

  14. Resch H, Pietschmann P, Krexner E, Willvonseder R (1991) Decreased peripheral bone mineral content in patients under anticoagulant therapy with phenprocoumon. Eur Heart J 12:439–441

    PubMed  CAS  Google Scholar 

  15. Fiore CE, Tamburino C, Foti R, Grimaldi D (1990) Reduced axial bone mineral content in patients taking an oral anticoagulant. South Med J 83:538–542

    PubMed  CAS  Google Scholar 

  16. Caraballo PJ, Gabriel SE, Castro MR, Atkinson EJ, Melton LJ III (1999) Changes in bone density after exposure to oral anticoagulants: a meta-analysis. Osteoporos Int 9:441–448

    Article  PubMed  CAS  Google Scholar 

  17. Caraballo PJ, Heit JA, Atkinson EJ, Silverstein MD, O’Fallon WM, Castro MR, Melton III LJ (1999) Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med 159:1750–1756

    Article  PubMed  CAS  Google Scholar 

  18. Jamal SA, Browner WS, Bauer DC, Cummings SR (1998) Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 128:829–832

    PubMed  CAS  Google Scholar 

  19. Rosen HN, Maitland LA, Suttie JW, Manning WJ, Glynn RJ, Greenspan SL (1993) Vitamin K and maintenance of skeletal integrity in adults. Am J Med 94:62–68

    Article  PubMed  CAS  Google Scholar 

  20. Booth SL, Broe KE, Gagnon DR, Tucker KL, Hannan MT, McLean RR, Dawson-Hughes B, Wilson PW, Cupples LA, Kiel DP (2003) Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr 77:512–516

    PubMed  CAS  Google Scholar 

  21. Booth SL, Tucker KL, Chen H, Hannan MT, Gagnon DR, Cupples LA, Wilson PWF, Ordovas J, Schaefer EJ, Dawson-Hughes B, Kiel DP (2000) Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 71:1201–1208

    PubMed  CAS  Google Scholar 

  22. Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA (1999) Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 69:74–79

    PubMed  CAS  Google Scholar 

  23. Jadad AR (1998) Randomised controlled trials. A user’s guide, 1st edn. BMJ Books, London

    Google Scholar 

  24. Mosekilde L, Hermann AP, Beck NH, Charles P, Nielsen SP, Sorensen OH (1999) The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2000 normal perimenopausal women. Maturitas 31:207–219

    Article  PubMed  CAS  Google Scholar 

  25. Vestergaard P, Hermann AP, Gram J, Jensen LB, Kolthoff N, Abrahamsen B, Brot C, Eiken P (1997) Improving compliance with hormonal replacement therapy in primary osteoporosis prevention. Maturitas 28:137–145

    Article  PubMed  CAS  Google Scholar 

  26. Moller A (1989) Food composition tables. Publication No. SC3. The Danish National Food Agency, Copenhagen

    Google Scholar 

  27. Abrahamsen B, Gram J, Hansen TB, Beck-Nielsen H (1995) Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone 16:385–390

    Article  PubMed  CAS  Google Scholar 

  28. The Food and Nutrition Board (2000) Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. National Academy Press, Washington, DC

    Google Scholar 

  29. Anon (2002) Human vitamin and mineral requirements: report of a joint FAO/WHO expert consultation, Bangkok, Thailand. World Health Organization, Food and Agriculture Organization of the United Nations, Rome, Italy

  30. Thane CW, Paul AA, Bates CJ, Bolton-Smith C, Prentice A, Shearer MJ (2002) Intake and sources of phylloquinone (vitamin K1): variation with socio-demographic and lifestyle factors in a national sample of British elderly people. Br J Nutr 87:605–613

    Article  PubMed  CAS  Google Scholar 

  31. Price R, Shearer MJ, Bolton-Smith C (1996) Daily and seasonal variation in phylloquinone (vitamin K1) intake in Scotland. Proc Nutr Soc 55:244A

    Google Scholar 

  32. Booth SL, Sokoll LJ, O’Brien ME, Tucker K, Dawson-Hughes B, Sadowski JA (1995) Assessment of dietary phylloquinone intake and vitamin K status in postmenopausal women. Eur J Clin Nutr 49:832–841

    PubMed  CAS  Google Scholar 

  33. Michels KB, Bingham SA, Luben R, Welch AA, Day NE (2004) The effect of correlated measurement error in multivariate models of diet. Am J Epidemiol 160:59–67

    Article  PubMed  Google Scholar 

  34. Ambrosini GL, de Klerk NH, Musk AW, Mackerras D (2001) Agreement between a brief food frequency questionnaire and diet records using two statistical methods. Public Health Nutr 4:255–264

    Article  PubMed  CAS  Google Scholar 

  35. McKeown NM, Rasmussen HM, Charnley JM, Wood RJ, Booth SL (2000) Accuracy of phylloquinone (vitamin K-1) data in 2 nutrient databases as determined by direct laboratory analysis of diets. J Am Diet Assoc 100:1201–1204

    Article  PubMed  CAS  Google Scholar 

  36. Braam LA, Knapen MH, Geusens P, Brouns F, Hamulyak K, Gerichhausen MJ, Vermeer C (2003) Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 73:21–26

    Article  PubMed  CAS  Google Scholar 

  37. Knapen MH, Hamulyak K, Vermeer C (1989) The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med 111:1001–1005

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The project was made possible by a grant from Karen Elise Jensen’s Foundation, Denmark. Drugs were provided free of charge by Novo Nordic, Denmark, Leo Pharmaceutical products A/S, Denmark, and Ciba Geigy, Denmark.

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism C, Aarhus Sygehus, Aarhus University Hospital, Tage-Hansens Gade 2, Aarhus C, 8000, Denmark

    L. Rejnmark, P. Vestergaard, P. Charles & L. Mosekilde

  2. Department of Endocrinology, Odense University Hospital, Odense, Denmark

    A. P. Hermann

  3. The Osteoporosis Research Centre, Hvidovre Hospital, Hvidovre, Denmark

    C. Brot

  4. Department of Endocrinology and Clinical Physiology and Nuclear Medicine, Hilleroed Hospital, Hilleroed, Denmark

    P. Eiken

Authors
  1. L. Rejnmark
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Vestergaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Charles
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. P. Hermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Brot
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Eiken
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Mosekilde
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Rejnmark.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rejnmark, L., Vestergaard, P., Charles, P. et al. No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women. Osteoporos Int 17, 1122–1132 (2006). https://doi.org/10.1007/s00198-005-0044-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-005-0044-3

Keywords

  • Bone mineral density
  • Fracture
  • Osteoporosis
  • Phylloquinone
  • Vitamin K
  • Women